| Product Code: ETC7628578 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland saw a significant increase in drug-device combination product imports, with top exporters being Germany, UK, USA, Canada, and other areas. The Herfindahl-Hirschman Index (HHI) indicated a shift from moderate to high concentration, reflecting market dynamics. The impressive compound annual growth rate (CAGR) of 23.25% from 2020 to 2024 highlights the expanding demand for these innovative products. Notably, the exceptional growth rate of 68.68% from 2023 to 2024 signals a rapidly evolving market landscape in Ireland for drug-device combination products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Drug-Device Combination Products Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Ireland Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Ireland Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Ireland Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Ireland Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Ireland Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Ireland leading to higher demand for drug-device combination products |
4.2.2 Technological advancements in drug-device combination products improving efficacy and patient outcomes |
4.2.3 Growing focus on personalized medicine and targeted therapies driving the adoption of drug-device combination products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of drug-device combination products |
4.3.2 High development costs and complexities associated with designing and manufacturing drug-device combination products |
4.3.3 Limited reimbursement policies for drug-device combination products impacting market penetration |
5 Ireland Drug-Device Combination Products Market Trends |
6 Ireland Drug-Device Combination Products Market, By Types |
6.1 Ireland Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Drug-Device Combination Products Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Ireland Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022 - 2032F |
6.1.4 Ireland Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022 - 2032F |
6.1.5 Ireland Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022 - 2032F |
6.1.6 Ireland Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022 - 2032F |
6.1.7 Ireland Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022 - 2032F |
6.1.8 Ireland Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022 - 2032F |
6.1.9 Ireland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.1.10 Ireland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Ireland Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.2.3 Ireland Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Ireland Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022 - 2032F |
6.2.5 Ireland Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022 - 2032F |
6.2.6 Ireland Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022 - 2032F |
6.2.7 Ireland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Ireland Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Ireland Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022 - 2032F |
6.3.3 Ireland Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022 - 2032F |
6.3.4 Ireland Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022 - 2032F |
6.3.5 Ireland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
7 Ireland Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Ireland Drug-Device Combination Products Market Export to Major Countries |
7.2 Ireland Drug-Device Combination Products Market Imports from Major Countries |
8 Ireland Drug-Device Combination Products Market Key Performance Indicators |
8.1 Number of successful product approvals by regulatory authorities |
8.2 Adoption rate of innovative drug-device combination products in clinical settings |
8.3 Investments in research and development for new drug-device combination products |
8.4 Patient satisfaction and outcomes data related to the use of drug-device combination products |
9 Ireland Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Ireland Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Ireland Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Ireland Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Ireland Drug-Device Combination Products Market - Competitive Landscape |
10.1 Ireland Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Ireland Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here